Mouse Models for Immunotherapy in Hepatocellular Carcinoma

Liver cancer is one of the dominant causes of cancer-related mortality, and the survival rate of liver cancer is among the lowest for all cancers. Immunotherapy for hepatocellular carcinoma (HCC) has yielded some encouraging results, but the percentage of patients responding to single-agent therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Enya, Lin, Li, Chen, Chia-Wei, Ou, Da-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896030/
https://www.ncbi.nlm.nih.gov/pubmed/31731753
http://dx.doi.org/10.3390/cancers11111800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896030/
https://www.ncbi.nlm.nih.gov/pubmed/31731753
http://dx.doi.org/10.3390/cancers11111800

Ejemplares similares